Update;Slides Telaprevir/Boceprevir-Efficacy and Safety

[Guest guest]

Update;Slides Telaprevir/Boceprevir-Efficacy and Safety

Drugs Advisory Committee Updates

TelaprevirFDA

Overview Of Clinical program / efficacy / safety

FDA Presentation for the April 28, 2011 Meeting of the Antiviral Drugs Advisory Committee (PDF – 321KB)

Rash Severity Grading

Vertex Backup Presentation for the April 28, 2011 Meeting of the Antiviral Drugs Advisory Committee (PDF – 143KB)5 (PDF - 142KB)

Telaprevir/Vertex Presentation

Vertex Main Presentation for the April 28, 2011 Meeting of the Antiviral Drugs Advisory Committee (PDF – 604KB)6 (PDF - 604KB)

Boceprevir

FDA,

FDA Presentation for the April 27, 2011 Meeting of the Antiviral Drugs Advisory Committee (PDF – 1.03MB)1,

Merck & Co., Inc

Merck Main Presentation for the April 27, 2011 Meeting of the Antiviral Drugs Advisory Committee (PDF – 346KB)2,

Merck Backup Presentation for the April 27, 2011 Meeting of the Antiviral Drugs Advisory Committee (PDF – 62KB)3

,

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.

View All Updates

http://Hepatitis Cnewdrugs.blogspot.com/2011/05/updateslides-telaprevirboceprevir.html